|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/47 | (2006.01) |
| A61K 31/445 | (2013.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61K 38/47 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/08 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) |
| (11) | Number of the document | 3871688 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20207542.0 |
| Date of filing the European patent application | 2013-05-02 | |
| (97) | Date of publication of the European application | 2021-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261642311 P | 2012-05-03 | US | |
| 201261664011 P | 2012-06-25 | US | |
| 201261697179 P | 2012-09-05 | US | |
| 201361749132 P | 2013-01-04 | US | |
| 201361749234 P | 2013-01-04 | US |
| (72) |
GREENE, Douglas Stuart , US
VALENZANO, Kenneth Joseph , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (54) | DOSING REGIMENS FOR THE TREATMENT OF POMPE DISEASE |
| DOSING REGIMENS FOR THE TREATMENT OF POMPE DISEASE |